Trial intelligence / Profile preview

Partial Versus Complete Pulpotomy in Primary Molars

NCT05190783Phase 4Completed

Sponsor
Mansoura University
Start
Mar 2019
Primary completion
Aug 2021
Modality
Implantable Devices
Countries
1
01

Overview

Phase 4, randomised, open-label trial of mineral trioxide aggregate and TheraCal in dental caries (6 arms), sponsored by Mansoura University. Primary endpoint: Post-operative pain at 15 months. Started Mar 2019; status: completed.

02

Drugs

mineral trioxide aggregateTheraCal
03

Conditions

dental caries

Beyond the preview

Go deeper on NCT05190783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05190783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call